全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Combination of LC-MS2 and GC-MS as a Tool to Differentiate Oxidative Metabolites of Zearalenone with Different Chemical Structures

DOI: 10.1155/2012/472031

Full-Text   Cite this paper   Add to My Lib

Abstract:

Recent studies on the mammalian and fungal metabolism of the mycotoxin zearalenone (ZEN) have disclosed the formation of six regioisomers of monohydroxy-ZEN and its reductive metabolite zearalenol (ZEL). Hydroxylation occurs at the aromatic ring or at one of four positions of the aliphatic macrocycle. In addition, an aliphatic ZEN epoxide, its hydrolysis product, and other products were identified in fungal cultures. In this paper, we report the product ion spectra of the [M-H]? ions of 22 oxidative metabolites of ZEN and ZEL, obtained by LC-MS2 analysis using a linear ion trap mass spectrometer with negative electrospray ionization. The MS2 spectra exhibit qualitative and quantitative differences which allow a clear distinction of most metabolites. Moreover, GC-MS analysis of the trimethylsilylated metabolites yields electron impact mass spectra with numerous fragment ions which can be used as fingerprint to confirm the chemical structure derived by LC-MS2 analysis. 1. Introduction Zearalenone (ZEN) is a mycotoxin with the chemical structure of a β-resorcylic acid lactone (Figure 1), which is produced by Fusarium species and frequently found as a contaminant of food and feed [1–3]. Due to its pronounced estrogenic activity, the exposure to ZEN has been associated with endocrine disruptive effects in domestic animals, especially in pigs, and possibly in humans [1, 4]. As is the case with virtually all other mycotoxins, ZEN is not the only congener produced by the fungus, and several other fungal resorcylic acid lactones have previously been identified, in particular the α- and β-stereoisomers of zearalenol (ZEL, Figure 1) and of 5-hydroxy-ZEN and 10-hydroxy-ZEN [5]. More recently, ZEN-11,12-oxide, ZEN-11,12-dihydrodiol and cyclization products of the latter have been reported as fungal metabolites [5]. Figure 1: Chemical structures of ZEN and ZEL. Arrows indicate positions of hydroxylation in fungal (f) and mammalian (m) metabolites. Nomenclature according to [ 6]. In addition to fungal metabolites of ZEN, numerous monohydroxylation products of ZEN and ZEL have recently been disclosed as mammalian metabolites in vitro [7–9]. Depending on the species, either the aromatic ring or the aliphatic macrocycle were the preferred site for hydroxylation (Figure 1). Taken together, fourteen oxidative ZEN and ZEL metabolites are presently known as regioisomers, that is, differing in the position of the hydroxyl group. The total number of oxidative metabolites is even higher, as hydroxylation at each aliphatic position gives rise to two stereoisomers. Although the

References

[1]  EFSA and European Food Safety Authority, “Scientific opinion on the risks for public health related to the presence of zearalenone in food,” EFSA Journal, vol. 9, no. 6, p. 2197, 2011.
[2]  K. Gromadska, A. Waskiewicz, J. Chelkowski, and P. Golinski, “Zearalenone and its metabolites: occurrence, detection, toxicity and guidelines,” World Mycotoxin Journal, vol. 1, pp. 209–220, 2008.
[3]  C. M. Maragos, “Zearalenone occurrence and human exposure,” World Mycotoxin Journal, vol. 3, no. 4, pp. 369–383, 2010.
[4]  M. Metzler, E. Pfeiffer, and A. A. Hildebrand, “Zearalenone and its metabolites as endocrine disrupting chemicals,” World Mycotoxin Journal, vol. 3, no. 4, pp. 385–401, 2010.
[5]  E. Pfeiffer, A. A. Hildebrand, C. Becker et al., “Identification of an aliphatic epoxide and the corresponding dihydrodiol as novel congeners of zearalenone in cultures of Fusarium graminearum,” Journal of agricultural and food chemistry, vol. 58, no. 22, pp. 12055–12062, 2010.
[6]  M. Metzler, “Proposal for a uniform designation of zearalenone and its metabolites,” Mycotoxin Research, vol. 27, no. 1, pp. 1–3, 2010.
[7]  E. Pfeiffer, A. Heyting, and M. Metzler, “Novel oxidative metabolites of the mycoestrogen zearalenone in vitro,” Molecular Nutrition and Food Research, vol. 51, no. 7, pp. 867–871, 2007.
[8]  E. Pfeiffer, A. Hildebrand, G. Damm et al., “Aromatic hydroxylation is a major metabolic pathway of the mycotoxin zearalenone in vitro,” Molecular Nutrition and Food Research, vol. 53, no. 9, pp. 1123–1133, 2009.
[9]  A. A. Hildebrand, E. Pfeiffer, A. Rapp, and M. Metzler, “Hydroxylation of the mycotoxin zearalenone at aliphatic positions: novel mammalian metabolites,” Mycotoxin Research, vol. 28, no. 1, pp. 1–8, 2012.
[10]  J. Reinen, L. L. Kalma, S. Begheijn, F. Heus, J. N. M. Commandeur, and N. P. E. Vermeulen, “Application of cytochrome P450 BM3 mutants as biocatalysts for the profiling of estrogen receptor binding metabolites of the mycotoxin zearalenone,” Xenobiotica, vol. 41, no. 1, pp. 59–70, 2011.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133